Free tool
Healthcare stocks
We cover 779 companies in the Healthcare sector. The median market value in the group is $579.92M. Across the group, the median move over the past trading day is −0.15%. 55% of the 762 with a 200-day average trade above it. Price change over the past year runs from −55.5% to +126.1% across the middle 80 percent of the group, with a median of +4.8%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
779 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% | Oct 14, 2026 |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% | Oct 29, 2026 |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% | Oct 29, 2026 |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% | Nov 3, 2026 |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% | Nov 3, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% | Oct 20, 2026 |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% | Nov 2, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% | Nov 2, 2026 |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% | Oct 29, 2026 |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% | Oct 29, 2026 |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% | Oct 20, 2026 |
| IUI1.DE | Intuitive Surgical, Inc. | $131.98B | Large cap | −21.06% | Oct 20, 2026 |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% | Oct 29, 2026 |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% | Oct 29, 2026 |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% | Oct 30, 2026 |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% | Oct 30, 2026 |
| SNY | Sanofi | $108.83B | Large cap | −4.33% | Oct 30, 2026 |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% | Nov 4, 2026 |
| GSK | GSK plc | $104.29B | Large cap | +32.23% | Oct 28, 2026 |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% | Oct 28, 2026 |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% | Oct 28, 2026 |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% | Oct 23, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% | Oct 28, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% | Oct 28, 2026 |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% | Nov 5, 2026 |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% | Nov 5, 2026 |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% | Oct 27, 2026 |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% | Oct 28, 2026 |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% | Oct 28, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% | Nov 4, 2026 |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% | Nov 5, 2026 |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% | Nov 5, 2026 |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% | Oct 29, 2026 |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% | Oct 29, 2026 |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% | Nov 3, 2026 |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% | Nov 3, 2026 |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% | Nov 5, 2026 |
| 207940.KS | Samsung Biologics Co.,Ltd. | $53.31B | Large cap | +2.12% | Oct 27, 2026 |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% | Oct 29, 2026 |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% | Oct 29, 2026 |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% | Nov 5, 2026 |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% | Nov 5, 2026 |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +28.99% | Oct 30, 2026 |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% | Nov 5, 2026 |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% | Nov 6, 2026 |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% | Nov 4, 2026 |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% | Nov 4, 2026 |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% | Nov 4, 2026 |
| IX1.DE | IDEXX Laboratories, Inc. | $44.14B | Large cap | +17.97% | Nov 2, 2026 |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% | Nov 2, 2026 |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% | Nov 3, 2026 |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% | Nov 5, 2026 |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% | Oct 30, 2026 |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% | Oct 29, 2026 |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% | Nov 4, 2026 |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% | Nov 10, 2026 |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% | Nov 10, 2026 |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% | Oct 29, 2026 |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% | Oct 29, 2026 |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% | Oct 29, 2026 |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% | Oct 29, 2026 |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% | Oct 29, 2026 |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% | Oct 28, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% | Oct 30, 2026 |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% | Oct 29, 2026 |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% | Oct 29, 2026 |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% | Oct 27, 2026 |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | −10.21% | Oct 29, 2026 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% | Oct 29, 2026 |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% | Nov 3, 2026 |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% | Nov 3, 2026 |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +11.19% | Oct 29, 2026 |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% | Nov 4, 2026 |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% | Nov 3, 2026 |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% | Nov 3, 2026 |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% | Nov 5, 2026 |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% | Nov 3, 2026 |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% | Oct 29, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% | Oct 29, 2026 |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% | Nov 9, 2026 |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% | Nov 3, 2026 |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% | Oct 27, 2026 |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% | Oct 22, 2026 |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% | Nov 11, 2026 |
| STE | STERIS plc | $23.09B | Large cap | −4.41% | Nov 4, 2026 |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% | Oct 28, 2026 |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% | Oct 27, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| SIG.AX | Sigma Healthcare Limited | $21.65B | Large cap | −15.21% | Aug 27, 2026 |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% | Nov 5, 2026 |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% | Nov 5, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% | Nov 5, 2026 |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% | Nov 5, 2026 |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% | Nov 5, 2026 |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% | Oct 28, 2026 |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% | Oct 19, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% | Oct 27, 2026 |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% | Nov 4, 2026 |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% | Nov 3, 2026 |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% | Nov 3, 2026 |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% | Oct 28, 2026 |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% | Nov 5, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% | Oct 28, 2026 |
| 4507.T | Shionogi & Co., Ltd. | $15.45B | Large cap | +15.63% | Oct 29, 2026 |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% | Nov 24, 2026 |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% | Nov 11, 2026 |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% | Nov 10, 2026 |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% | Sep 9, 2026 |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% | Nov 4, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% | Oct 29, 2026 |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% | Oct 28, 2026 |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% | Oct 21, 2026 |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% | Nov 4, 2026 |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% | Nov 4, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% | Oct 26, 2026 |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% | Nov 3, 2026 |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% | Nov 10, 2026 |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% | Nov 5, 2026 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% | Nov 24, 2026 |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% | Nov 3, 2026 |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% | Nov 4, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% | Nov 2, 2026 |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% | Nov 3, 2026 |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% | Oct 28, 2026 |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% | Oct 28, 2026 |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% | Oct 19, 2026 |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% | Nov 9, 2026 |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% | Oct 30, 2026 |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% | Oct 28, 2026 |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% | Oct 28, 2026 |
| GMED | Globus Medical, Inc. | $11.16B | Large cap | +35.10% | Nov 5, 2026 |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% | Nov 5, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% | Nov 2, 2026 |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% | Oct 28, 2026 |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% | Nov 2, 2026 |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% | Oct 21, 2026 |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% | Nov 4, 2026 |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% | Nov 9, 2026 |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% | Oct 26, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% | Nov 3, 2026 |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% | Nov 3, 2026 |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% | Oct 29, 2026 |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% | Nov 3, 2026 |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% | Nov 3, 2026 |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% | Nov 9, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% | Sep 21, 2026 |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% | Oct 22, 2026 |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% | Sep 21, 2026 |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% | Nov 5, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% | Oct 22, 2026 |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% | Nov 12, 2026 |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% | Nov 5, 2026 |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% | Nov 5, 2026 |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% | Nov 4, 2026 |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% | Oct 20, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% | Nov 12, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% | Nov 5, 2026 |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% | Nov 5, 2026 |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% | Nov 12, 2026 |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% | Nov 9, 2026 |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% | Nov 5, 2026 |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% | Nov 9, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% | Nov 4, 2026 |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% | Nov 9, 2026 |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% | Nov 3, 2026 |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% | Nov 5, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% | Nov 5, 2026 |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +10.98% | Nov 9, 2026 |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% | Nov 12, 2026 |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% | Nov 2, 2026 |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% | Nov 6, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% | Nov 2, 2026 |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% | Nov 5, 2026 |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% | Nov 11, 2026 |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% | Nov 6, 2026 |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% | Nov 5, 2026 |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.96% | Nov 12, 2026 |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +52.27% | Nov 5, 2026 |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% | Nov 16, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% | Nov 10, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −24.33% | Nov 12, 2026 |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% | Nov 3, 2026 |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% | Nov 11, 2026 |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% | Nov 5, 2026 |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% | Nov 16, 2026 |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% | Nov 5, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| 8086.T | Nipro Corporation | $1.57B | Small cap | +4.28% | Nov 10, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% | Oct 22, 2026 |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% | Nov 4, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% | Sep 14, 2026 |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% | Nov 12, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% | Nov 16, 2026 |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% | Nov 4, 2026 |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% | Nov 4, 2026 |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% | Oct 29, 2026 |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% | Nov 13, 2026 |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% | Nov 5, 2026 |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% | Oct 29, 2026 |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −7.26% | Nov 10, 2026 |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% | Nov 5, 2026 |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% | Nov 5, 2026 |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% | Oct 29, 2026 |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% | Sep 8, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% | Nov 12, 2026 |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% | Nov 20, 2026 |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% | Nov 5, 2026 |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% | Nov 4, 2026 |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% | Nov 4, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% | Oct 29, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% | Nov 12, 2026 |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% | Nov 11, 2026 |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% | Nov 12, 2026 |
| 4483.T | JMDC Inc. | $1.42B | Small cap | −17.21% | Nov 5, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% | Oct 16, 2026 |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% | Nov 17, 2026 |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% | Nov 12, 2026 |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% | Nov 12, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% | Nov 19, 2026 |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% | Sep 14, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.25% | Nov 10, 2026 |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% | Nov 5, 2026 |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% | Nov 4, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% | Nov 5, 2026 |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% | Nov 5, 2026 |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% | Nov 5, 2026 |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% | Nov 4, 2026 |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% | Nov 5, 2026 |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% | Nov 5, 2026 |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% | Oct 29, 2026 |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% | Nov 12, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% | Nov 11, 2026 |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% | Nov 5, 2026 |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% | Nov 3, 2026 |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% | Nov 5, 2026 |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +54.71% | Oct 29, 2026 |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% | Nov 5, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% | Nov 5, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% | Nov 3, 2026 |
| SNZ.AX | Summerset Group Holdings Limited | $1.22B | Small cap | −26.63% | Aug 27, 2026 |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.65% | Nov 9, 2026 |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% | Nov 11, 2026 |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% | Nov 4, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.86% | Nov 13, 2026 |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% | Nov 4, 2026 |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% | Nov 3, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% | Nov 5, 2026 |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% | Oct 28, 2026 |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% | Nov 11, 2026 |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% | Nov 12, 2026 |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% | Nov 11, 2026 |
| IVA.PA | Inventiva S.A. | $1.14B | Small cap | −14.63% | Sep 25, 2026 |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% | Nov 5, 2026 |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% | Sep 25, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% | Nov 13, 2026 |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% | Oct 21, 2026 |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% | Nov 3, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% | Oct 28, 2026 |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.31% | Oct 30, 2026 |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% | Nov 12, 2026 |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.06B | Small cap | −1.28% | Oct 30, 2026 |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% | Nov 2, 2026 |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% | Nov 2, 2026 |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% | Nov 5, 2026 |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% | Nov 2, 2026 |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% | Nov 9, 2026 |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% | Nov 16, 2026 |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% | Nov 6, 2026 |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% | Aug 27, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% | Nov 5, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% | Nov 4, 2026 |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% | Nov 12, 2026 |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% | Oct 15, 2026 |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% | Oct 29, 2026 |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% | Nov 5, 2026 |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% | Sep 11, 2026 |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% | Nov 3, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% | Nov 12, 2026 |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $949.35M | Small cap | +10.07% | Nov 10, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% | Nov 9, 2026 |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% | Nov 9, 2026 |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% | Oct 28, 2026 |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% | Nov 5, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% | Oct 22, 2026 |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −22.48% | Oct 9, 2026 |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% | Nov 5, 2026 |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% | Oct 28, 2026 |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% | Nov 3, 2026 |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% | Nov 11, 2026 |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% | Nov 5, 2026 |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% | Nov 10, 2026 |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% | Nov 12, 2026 |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +54.36% | Nov 13, 2026 |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% | Oct 29, 2026 |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% | Oct 27, 2026 |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% | Nov 12, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% | Nov 3, 2026 |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% | Nov 4, 2026 |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% | Oct 23, 2026 |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% | Nov 9, 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% | Nov 10, 2026 |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% | Nov 5, 2026 |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% | Nov 6, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% | Nov 5, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% | Sep 23, 2026 |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% | Nov 5, 2026 |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% | Nov 2, 2026 |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% | Sep 29, 2026 |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% | Nov 5, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% | Nov 3, 2026 |
| WELL.TO | WELL Health Technologies Corp. | $807.72M | Small cap | −8.18% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% | Nov 12, 2026 |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% | Nov 12, 2026 |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% | Nov 12, 2026 |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% | Nov 17, 2026 |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% | Nov 3, 2026 |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% | Nov 12, 2026 |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% | Nov 12, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% | Nov 11, 2026 |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% | Nov 3, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% | Nov 5, 2026 |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% | Nov 5, 2026 |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% | Sep 2, 2026 |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% | Oct 27, 2026 |
| DHT-UN.TO | DRI Healthcare Trust | $714.70M | Small cap | +27.29% | Nov 5, 2026 |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% | Oct 29, 2026 |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% | Nov 9, 2026 |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% | Nov 5, 2026 |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% | Nov 5, 2026 |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% | Nov 5, 2026 |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% | Nov 4, 2026 |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% | Nov 4, 2026 |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% | Nov 5, 2026 |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% | Oct 29, 2026 |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% | Nov 9, 2026 |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% | Nov 5, 2026 |
| GMRS | GMR Solutions Inc. | $692.56M | Small cap | −8.30% | Nov 16, 2026 |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% | Nov 5, 2026 |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% | Nov 12, 2026 |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% | Nov 4, 2026 |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% | Nov 12, 2026 |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% | Nov 16, 2026 |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% | Nov 6, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| 4565.T | Nxera Pharma Co., Ltd. | $648.21M | Small cap | +22.68% | Oct 30, 2026 |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% | Oct 28, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% | Nov 3, 2026 |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% | Oct 8, 2026 |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% | Oct 29, 2026 |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% | Oct 28, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% | Nov 5, 2026 |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% | Nov 16, 2026 |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% | Nov 4, 2026 |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% | Nov 5, 2026 |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% | Nov 12, 2026 |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% | Nov 4, 2026 |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% | Nov 5, 2026 |
| EQS.PA | Equasens Société anonyme | $588.00M | Small cap | −25.98% | Sep 28, 2026 |
| WEAV | Weave Communications, Inc. | $584.79M | Small cap | −5.68% | Nov 5, 2026 |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% | Nov 4, 2026 |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% | Nov 10, 2026 |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% | Nov 12, 2026 |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% | Nov 3, 2026 |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% | Nov 10, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% | Nov 3, 2026 |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% | Nov 11, 2026 |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% | Nov 5, 2026 |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% | Nov 5, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% | Nov 11, 2026 |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% | Nov 16, 2026 |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% | Nov 6, 2026 |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% | Nov 9, 2026 |
| TCMD | Tactile Systems Technology, Inc. | $532.56M | Small cap | +78.78% | Nov 2, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% | Nov 5, 2026 |
| 4480.T | Medley, Inc. | $512.99M | Small cap | +9.22% | Nov 12, 2026 |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% | Nov 9, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% | Nov 5, 2026 |
| NPCE | NeuroPace, Inc. | $503.88M | Small cap | +65.32% | Nov 3, 2026 |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% | Nov 16, 2026 |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% | Nov 5, 2026 |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% | Sep 14, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% | Nov 4, 2026 |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% | Nov 6, 2026 |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% | Nov 3, 2026 |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% | Nov 6, 2026 |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% | Nov 9, 2026 |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% | Nov 3, 2026 |
| NRC | NRC Health | $487.06M | Small cap | +45.92% | Oct 26, 2026 |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% | Nov 12, 2026 |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% | Sep 16, 2026 |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% | Nov 5, 2026 |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% | Nov 9, 2026 |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% | Nov 10, 2026 |
| OCGN | Ocugen, Inc. | $478.15M | Small cap | +35.58% | Nov 5, 2026 |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% | Nov 5, 2026 |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% | Nov 5, 2026 |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% | Nov 5, 2026 |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% | Nov 5, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% | Nov 5, 2026 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% | Nov 9, 2026 |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% | Sep 22, 2026 |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% | Nov 11, 2026 |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% | Nov 5, 2026 |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% | Nov 5, 2026 |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% | Nov 5, 2026 |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% | Nov 4, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% | Nov 12, 2026 |
| MASS | 908 Devices Inc. | $428.63M | Small cap | +64.60% | Nov 10, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% | Nov 12, 2026 |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $422.50M | Small cap | −19.86% | Nov 9, 2026 |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% | Nov 4, 2026 |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% | Nov 5, 2026 |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% | Nov 16, 2026 |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% | Oct 28, 2026 |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% | Oct 29, 2026 |
| RCKT | Rocket Pharmaceuticals, Inc. | $401.78M | Small cap | +10.24% | Nov 5, 2026 |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% | Aug 27, 2026 |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% | Nov 5, 2026 |
| OFIX | Orthofix Medical Inc. | $397.14M | Small cap | −34.30% | Nov 3, 2026 |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +315.53% | Nov 12, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% | Nov 4, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% | Nov 6, 2026 |
| TKNO | Alpha Teknova, Inc. | $387.63M | Small cap | +62.25% | Nov 5, 2026 |
| MOBI | Mobia Medical, Inc. | $387.35M | Small cap | −0.85% | Nov 9, 2026 |
| AUNA | Auna SA | $387.31M | Small cap | −16.85% | Nov 19, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% | Oct 29, 2026 |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% | Nov 5, 2026 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% | Nov 10, 2026 |
| VHI.TO | Vitalhub Corp. | $364.45M | Small cap | −36.39% | Nov 5, 2026 |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% | Nov 6, 2026 |
| DMAC | DiaMedica Therapeutics Inc. | $361.30M | Small cap | +12.04% | Nov 11, 2026 |
| CATX | Perspective Therapeutics, Inc. | $360.72M | Small cap | −12.47% | Nov 9, 2026 |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% | Nov 9, 2026 |
| ALCLS.PA | Cellectis S.A. | $355.75M | Small cap | +27.74% | Nov 13, 2026 |
| VMD | Viemed Healthcare, Inc. | $355.36M | Small cap | +29.94% | Nov 4, 2026 |
| SABS | SAB Biotherapeutics, Inc. | $353.03M | Small cap | +83.02% | Nov 12, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% | Nov 13, 2026 |
| CLLS | Cellectis S.A. | $344.40M | Small cap | +28.09% | Nov 13, 2026 |
| ABEO | Abeona Therapeutics Inc. | $343.68M | Small cap | −12.90% | Nov 11, 2026 |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $338.48M | Small cap | −24.94% | Aug 27, 2026 |
| IMRX | Immuneering Corporation | $333.19M | Small cap | −0.77% | Nov 11, 2026 |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% | Nov 5, 2026 |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% | Nov 5, 2026 |
| ILM1.DE | Medios AG | $324.14M | Small cap | −26.32% | Nov 10, 2026 |
| VNDA | Vanda Pharmaceuticals Inc. | $323.48M | Small cap | +15.80% | Nov 4, 2026 |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% | Nov 12, 2026 |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% | Nov 11, 2026 |
| OBIO | Orchestra BioMed Holdings, Inc. | $316.15M | Small cap | +85.21% | Nov 5, 2026 |
| IRD | Opus Genetics, Inc. | $316.14M | Small cap | +216.67% | Nov 11, 2026 |
| VICO.ST | Vicore Pharma Holding AB (publ) | $315.07M | Small cap | −1.29% | Nov 5, 2026 |
| RNAC | Cartesian Therapeutics, Inc. | $308.30M | Small cap | −4.09% | Nov 5, 2026 |
| 7779.T | CYBERDYNE Inc. | $307.38M | Small cap | +12.08% | Nov 12, 2026 |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% | Nov 5, 2026 |
| EBS | Emergent BioSolutions Inc. | $306.10M | Small cap | −30.50% | Oct 28, 2026 |
| FATE | Fate Therapeutics, Inc. Common Stock | $305.54M | Small cap | +129.46% | Nov 12, 2026 |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% | Oct 29, 2026 |
| TLSI | TriSalus Life Sciences, Inc. | $303.56M | Small cap | −3.33% | Nov 12, 2026 |
| AMRN | Amarin Corporation plc | $301.43M | Small cap | −7.08% | Oct 28, 2026 |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% | Nov 24, 2026 |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% | Nov 2, 2026 |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% | Nov 5, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% | Nov 3, 2026 |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% | Oct 29, 2026 |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.